Biweekly CHOP biweekly THP-COP regimen in the treatment of aggressive non-Hodgkin's lymphoma - Comparison of doxorubicin and pirarubicin: A randomized phase II study.

被引：0
|
作者：
Tsurumi, H
Sawada, M
Yamada, T
Hara, T
Goto, H
Fukuno, K
Shimizu, M
Yoshikawa, T
Kanemura, N
Takahashi, T
Oyama, M
Ozawa, K
Moriwaki, H
机构：
[1] Gifu Univ, Sch Med, Dept Internal Med 1, Gifu 500, Japan
[2] Kisogawa Hosp, Dept Internal Med, Kisogawa, Aichi, Japan
[3] Takayama Red Cross Hosp, Dept Internal Med, Takayama, Gifu, Japan
[4] Gifu Municipal Hosp, Dept Hematol, Gifu, Japan
[5] Jichi Med Sch, Dept Hematol, Minami Kawachi, Tochigi 32904, Japan
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1460
引用
收藏
页码：346A / 346A
页数：1
相关论文
共 50 条
  • [1] Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma - A comparison of doxorubicin and pirarubicin: a randomized phase II study
    Tsurumi, H
    Yamada, T
    Sawada, M
    Kasahara, S
    Kanemura, N
    Kojima, Y
    Fukuno, K
    Hara, T
    Saio, M
    Takahashi, T
    Oyama, M
    Ozawa, K
    Takami, T
    Moriwaki, H
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (02) : 107 - 113
  • [2] Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin’s lymphomaA comparison of doxorubicin and pirarubicin: a randomized phase II study
    Hisashi Tsurumi
    Toshiki Yamada
    Michio Sawada
    Senji Kasahara
    Nobuhiro Kanemura
    Yasushi Kojima
    Kenji Fukuno
    Takeshi Hara
    Masanao Saio
    Takeshi Takahashi
    Masami Oyama
    Keiya Ozawa
    Tsuyoshi Takami
    Hisataka Moriwaki
    [J]. Journal of Cancer Research and Clinical Oncology, 2004, 130 : 107 - 113
  • [3] Randomized comparison of standard CHOP and biweekly CHOP with prophylactic using G-CSF in aggressive non-Hodgkin's lymphoma
    Lin, T
    Guan, ZZ
    He, YJ
    Jiang, WQ
    Liu, DG
    Su, XH
    Xu, RH
    Huang, HQ
    Ten, XY
    Li, YH
    Huang, H
    Zhou, ZM
    [J]. BLOOD, 2003, 102 (11) : 405A - 405A
  • [4] Phase II clinical study of rituximab and high-dose biweekly THP-COP (pirarubicin, cyclophosphamide, vincristine and predonisolone) with G-CSF for non-Hodgkin lymphoma: Results of a multicentric study of NMLSG (Niigata Malignant Lymphoma Study Group).
    Takizawa, J
    Aoki, S
    Takai, K
    Kurasaki, T
    Honma, K
    Higashimura, M
    Nagai, K
    Momoi, A
    Nikkuni, K
    Aizawa, Y
    [J]. BLOOD, 2005, 106 (11) : 264B - 264B
  • [5] CHOP compared to THP-COP regimen: Long-term outcome in Chinese non-Hodgkin lymphoma (NHL) patients
    Zhai, L.
    Cheng, C.
    Niraula, S.
    Huang, Y.
    Li, Z. M.
    Wang, S. S.
    Huang, H. Q.
    Lin, T. Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin
    Shibata, Yuhei
    Hara, Takeshi
    Kasahara, Senji
    Yamada, Toshiki
    Sawada, Michio
    Mabuchi, Ryoko
    Matsumoto, Takuro
    Nakamura, Nobuhiko
    Nakamura, Hiroshi
    Ninomiya, Soranobu
    Kitagawa, Junichi
    Kanemura, Nobuhiro
    Kito, Yusuke
    Goto, Naoe
    Miyazaki, Tatsuhiko
    Takami, Tsuyoshi
    Takeuchi, Tamotsu
    Shimizu, Masahito
    Tsurumi, Hisashi
    [J]. HEMATOLOGICAL ONCOLOGY, 2017, 35 (02) : 163 - 171
  • [7] Clinical experience with biweekly CHOP plus rituximab chemoimmunotherapy for the treatment of aggressive B-cell non-Hodgkin lymphoma
    Aguiar Bujanda, David
    Aguiar Morales, Jose
    Bohn Sarmiento, Uriel
    Saura Grau, Salvador
    Rodriguez Franco, Carlos
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (09): : 604 - 608
  • [8] Clinical experience with biweekly CHOP plus rituximab chemoimmunotherapy for the treatment of aggressive B-cell non-Hodgkin lymphoma
    David Aguiar Bujanda
    José Aguiar Morales
    Uriel Bohn Sarmiento
    Salvador Saura Grau
    Carlos Rodríguez Franco
    [J]. Clinical and Translational Oncology, 2009, 11 : 604 - 608
  • [9] A randomized comparison of ACVBP and CHOP in the treatment of advanced aggressive non-Hodgkin's lymphoma: The LNH93-5 study.
    Tilly, H
    Lepage, E
    Coiffier, B
    Blanc, M
    Herbrecht, R
    Bosly, A
    Attal, M
    Fillet, G
    Guettier, C
    Molina, T
    Gisselbrecht, C
    Reyes, F
    [J]. BLOOD, 2000, 96 (11) : 832A - 832A
  • [10] Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphoma
    Limat, S
    Demesmay, K
    Voillat, L
    Bernard, Y
    Deconinck, E
    Brion, A
    Sabbah, A
    Woronoff-Lemsi, MC
    Cahn, JY
    [J]. ANNALS OF ONCOLOGY, 2003, 14 (02) : 277 - 281
12345